GOLDMAN SACHS GROUP INC
Former 10% Owner
127 filings on record here, covering ATTO, ACT, APUR. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-13
| Buy | ATTO | Attovia Therapeutics, Inc. | $1,785,000 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $21,766 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $9,776 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $29,344 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $4,410 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $34,325 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $74,912 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $4,420 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $10,344 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $2,211 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $16,543 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $14,797 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $153,549 |
| Sell | ATTO | Attovia Therapeutics, Inc. | $8,808 |
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-13
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-12
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-11
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-10
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-08-06
CORPORATEFiled 2026-07-30
CORPORATEFiled 2026-07-30
CORPORATEFiled 2026-07-30
CORPORATEFiled 2026-07-30
CORPORATEFiled 2026-07-30
CORPORATEFiled 2026-07-29
CORPORATEFiled 2026-07-29
CORPORATEFiled 2026-07-29
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-28
CORPORATEFiled 2026-07-27
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-24
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-23
CORPORATEFiled 2026-07-13
CORPORATEFiled 2026-07-13
CORPORATEFiled 2026-07-13
CORPORATEFiled 2026-07-13
CORPORATEFiled 2026-07-13
CORPORATEFiled 2026-07-10
CORPORATEFiled 2026-07-10
CORPORATEFiled 2026-07-10
CORPORATEFiled 2026-07-09
CORPORATEFiled 2026-07-08
CORPORATEFiled 2026-07-08
CORPORATEFiled 2026-07-08
CORPORATEFiled 2026-07-02
CORPORATEFiled 2026-07-01
| Sell | ACT | Enact Holdings, Inc. | $25,580,418 |
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-30
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-29
CORPORATEFiled 2026-06-26
CORPORATEFiled 2026-06-26
CORPORATEFiled 2026-06-26
CORPORATEFiled 2026-06-24
CORPORATEFiled 2026-06-23
CORPORATEFiled 2026-06-22
CORPORATEFiled 2026-06-18
CORPORATEFiled 2026-06-18
CORPORATEFiled 2026-06-17
| Sell | APUR | Aperture AC | $10 |
| Sell | APUR | Aperture AC | $218 |
| Sell | APUR | Aperture AC | $248 |
CORPORATEFiled 2026-06-16
CORPORATEFiled 2026-06-16
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
CORPORATEFiled 2026-06-15
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.